- Patient/Guest
- Phlebotomist
- Updates
| Cardiac Enzymes | - |
|---|
|
Measure cardiac enzyme levels |
||
 |
Synonym | See updates |
 |
Test Code | CDBIOPR0006 |
 |
Test Type | Biochemistry |
 |
Pre-Test Condition | See updates |
 |
Report Availability | 1 D(s) |
 |
# Test(s) | Multiple |
| Test details | Sample Report |
|---|---|
| Cardiac Enzymes |
|
|
Synonym | See updates | |
|
Test Code | CDBIOPR0006 | |
 |
Test Category | Cardiac disorders | |
|
Pre-Test Condition | See updates | |
 |
Medical History | See updates | |
|
Report Availability | 1 D(s) | |
 |
Specimen/Sample | Serum; 2 mL; SST | |
 |
Stability @21-26 deg. C | 6 Hr(s) | |
 |
Stability @ 2-8 deg. C | 7 D(s) | |
 |
Stability @ Frozen | 1 M(s) | |
|
# Test(s) | Multiple | |
 |
Processing Method | Chemiluminescence | |
| **Cardiac Enzymes Profile****FDA Status**: Standard laboratory procedure under CLIA; no specific FDA approval required.**Other Names**: Cardiac Biomarker Test, Troponin/CK-MB Profile.**Historical Breakthrough**: Developed in the 1980s to diagnose myocardial infarction, advancing cardiology.**Key Purpose and Impact**: Measures cardiac enzymes (e.g., troponin, CK-MB) to diagnose heart attack or cardiac injury.**Preparation and Patient History**: Blood; report chest pain, dyspnea, or cardiac history.**Consent Requirement**: Standard consent for diagnostic testing.**Clinical Value**: Sensitivity ~95%; specificity ~95%; detects MI in ~90% of cases; guides therapy.**References Cited**: Testing.com Cardiac Tests 2023; Labcorp Cardiac Enzymes Test 2025; UpToDate Myocardial Infarction 2025 |